National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 7/15/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jeremy S. Abramson, MD

None

Celgene Corporation;
Genentech, Inc.;
Genzyme Corporation

None

None

4/16/2013

Ranjana H. Advani, MD

None

Genentech, Inc.;
Allos Therapeutics;
Pharmacyclics Inc.;
Seattle Genetics

None

None

7/17/2013

C. Babis Andreadis, MD, MSCE

None

Allos

None

None

5/16/2013

Nancy Bartlett, MD

None

None

None

None

4/14/2014

Naresh Bellam, MD, MPH

None

None

None

None

7/16/2013

R. Gregory Bociek, MD, MSc

None

None

None

None

6/11/2012

John C. Byrd, MD

None

None

None

None

3/26/2013

Myron S. Czuczman, MD

None

Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
GlaxoSmithKline

None

None

7/24/2013

Mary Dwyer, MS

None

None

None

None

3/7/2014

Luis E. Fayad, MD

Centocor, Inc.;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Wyeth Pharmaceuticals

None

None

None

9/18/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Martha J. Glenn, MD

None

None

None

None

6/7/2013

Jon P. Gockerman, MD

None

Novartis Pharmaceuticals Corporation

None

None

6/11/2012

Leo I. Gordon, MD

None

CureTech Ltd.

None

CureTech Ltd.

6/20/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Nancy Lee Harris, MD

None

None

None

None

7/17/2013

Richard T. Hoppe, MD

None

None

None

None

9/10/2013

Steven M. Horwitz, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation;
Genzyme Corporation;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Allos;
Seattle Genetics

None

None

8/23/2013

Christopher R. Kelsey, MD

None

None

None

None

3/5/2013

Youn H. Kim, MD

None

Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Allos therapeutics;
Kyowa

None

None

3/10/2013

Susan Krivacic, MPAff

None

None

None

None

2/11/2013

Ann S. LaCasce, MD

None

None

None

None

3/4/2013

Joan S. McClure, MS

None

None

None

None

8/13/2013

Auayporn Nademanee, MD

None

Spectrum Phamaceuticals

None

None

3/15/2013

Pierluigi Porcu, MD

None

Therakos, Inc.

None

None

3/4/2013

Oliver Press, MD, PhD

None

Millennium Pharmaceuticals, Inc.;
Algeta;
Emergent Biosolutions;
Inimex;
Zymogenetics;
Roche Laboratories, Inc.

Emergent Biosolutions

None

4/7/2014

Barbara Pro, MD

None

None

None

None

1/17/2012

Nishitha Reddy, MD

None

None

None

None

11/21/2013

Lubomir Sokol, MD, PhD

None

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Eisai Inc.;
Eisai Inc.;
MedImmune Inc.;
Allos

None

None

11/8/2013

Lode J. Swinnen, MB, ChB

None

None

None

None

11/6/2013

Christina Tsien, MD

None

None

None

None

3/5/2013

Julie M. Vose, MD, MBA

None

None

None

None

3/5/2013

William G. Wierda, MD, PhD

None

Celgene Corporation;
Genentech, Inc.;
Micromet;
Roche Laboratories, Inc.

None

None

3/4/2013

Joachim Yahalom, MD

None

None

None

None

10/17/2013

Nadeem Zafar, MD

None

None

None

None

10/8/2012

Andrew D. Zelenetz, MD, PhD

None

Abbott Laboratories;
Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Allos;
Cancer Genetics;
Seattle Genetics;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

6/12/2013